These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12555049)

  • 1. Comparing the sensitivity of generic effectiveness measures with symptom improvement in persons with schizophrenia.
    Pyne JM; Sullivan G; Kaplan R; Williams DK
    Med Care; 2003 Feb; 41(2):208-17. PubMed ID: 12555049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective analysis of clinical evaluation and self-assessment by patients after decompression surgery for degenerative lumbar canal stenosis.
    Haro H; Maekawa S; Hamada Y
    Spine J; 2008; 8(2):380-4. PubMed ID: 17433781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-adjusted health status in veterans with posttraumatic stress disorder.
    Mancino MJ; Pyne JM; Tripathi S; Constans J; Roca V; Freeman T
    J Nerv Ment Dis; 2006 Nov; 194(11):877-9. PubMed ID: 17102715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
    J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generic effectiveness measures: sensitivity to symptom change in anxiety disorders.
    Perini SJ; Slade T; Andrews G
    J Affect Disord; 2006 Feb; 90(2-3):123-30. PubMed ID: 16337690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the minimum clinically important difference in quality of life in schizophrenia measured by the Quality of Well-Being Scale and disease-specific measures.
    Thwin SS; Hermes E; Lew R; Barnett P; Liang M; Valley D; Rosenheck R
    Psychiatry Res; 2013 Oct; 209(3):291-6. PubMed ID: 23473656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
    Chino B; Nemoto T; Fujii C; Mizuno M
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study on quality of life of patients of schizophrenia with and without depression.
    Dan A; Kumar S; Avasthi A; Grover S
    Psychiatry Res; 2011 Sep; 189(2):185-9. PubMed ID: 21453977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic validity of assessment scales for depression in patients with schizophrenia.
    Kim SW; Kim SJ; Yoon BH; Kim JM; Shin IS; Hwang MY; Yoon JS
    Psychiatry Res; 2006 Sep; 144(1):57-63. PubMed ID: 16904189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the EQ-5D measure quality of life in schizophrenia?
    Halling Hastrup L; Nordentoft M; Hjorthøj C; Gyrd-Hansen D
    J Ment Health Policy Econ; 2011 Dec; 14(4):187-96. PubMed ID: 22345360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sensitivity of quality-of-life scale WHOQOL-100 to psychopathological measures in schizophrenia.
    Orsel S; Akdemir A; Dağ I
    Compr Psychiatry; 2004; 45(1):57-61. PubMed ID: 14671738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of thought disorders on quality of life in patients with schizophrenia.
    Ulas H; Akdede BB; Ozbay D; Alptekin K
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):332-5. PubMed ID: 17854967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
    Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
    J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric comorbidity in first episode schizophrenia: a 2 year, longitudinal outcome study.
    Sim K; Chua TH; Chan YH; Mahendran R; Chong SA
    J Psychiatr Res; 2006 Oct; 40(7):656-63. PubMed ID: 16904688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quality of life in patients with schizophrenia: a study of 100 cases].
    Zouari L; Thabet JB; Elloumi Z; Elleuch M; Zouari N; Maâlej M
    Encephale; 2012 Apr; 38(2):111-7. PubMed ID: 22516268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary longitudinal assessment of quality of life in patients with major depression.
    Pyne JM; Patterson TL; Kaplan RM; Ho S; Gillin JC; Golshan S; Grant I
    Psychopharmacol Bull; 1997; 33(1):23-9. PubMed ID: 9133748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of well-being in older people with osteoarthritis.
    Groessl EJ; Kaplan RM; Cronan TA
    Arthritis Rheum; 2003 Feb; 49(1):23-8. PubMed ID: 12579590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Generic quetiapine in the treatment of acute schizophrenia and schizoaffective disorder].
    György B; Robert K; László C; Andrea J;
    Neuropsychopharmacol Hung; 2008 Dec; 10(5):293-303. PubMed ID: 19419015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of ziprasidone in treating impaired quality of life in schizophrenia: a 12-month, open-label, flexible-dose, naturalistic observational study of patients undergoing usual care.
    Ritsner MS; Yorkov V; Ratner Y; Soifer P; Gibel A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1470-7. PubMed ID: 17669573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.